{"id":"https://openalex.org/W2026579653","doi":"https://doi.org/10.1158/1538-7445.am2011-2488","title":"Abstract 2488: Co-targeting EGFR and IGF-1R to sensitize or overcome induced resistance of head and neck cancer models to radiation","display_name":"Abstract 2488: Co-targeting EGFR and IGF-1R to sensitize or overcome induced resistance of head and neck cancer models to radiation","publication_year":2011,"publication_date":"2011-04-01","ids":{"openalex":"https://openalex.org/W2026579653","doi":"https://doi.org/10.1158/1538-7445.am2011-2488","mag":"2026579653"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2011-2488","doi":"https://doi.org/10.1158/1538-7445.am2011-2488","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2011-2488","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109799014","display_name":"Uma Raju","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Uma Raju","raw_affiliation_strings":["1UT M.D. Anderson Cancer Ctr., Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT M.D. Anderson Cancer Ctr., Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007512249","display_name":"Fumihiko Matsumoto","orcid":"https://orcid.org/0000-0002-0802-8011","observed_orcids":["https://orcid.org/0000-0002-0802-8011"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fumihiko Matsumoto","raw_affiliation_strings":["1UT M.D. Anderson Cancer Ctr., Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT M.D. Anderson Cancer Ctr., Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083198568","display_name":"David P. Molkentine","orcid":"https://orcid.org/0000-0003-0505-6815","observed_orcids":["https://orcid.org/0000-0003-0505-6815"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David P. Molkentine","raw_affiliation_strings":["1UT M.D. Anderson Cancer Ctr., Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT M.D. Anderson Cancer Ctr., Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053516369","display_name":"Jessica M. Molkentine","orcid":"https://orcid.org/0000-0002-3757-7167","observed_orcids":["https://orcid.org/0000-0002-3757-7167"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica M. Molkentine","raw_affiliation_strings":["1UT M.D. Anderson Cancer Ctr., Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT M.D. Anderson Cancer Ctr., Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108796110","display_name":"Luka Milas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Luka Milas","raw_affiliation_strings":["1UT M.D. Anderson Cancer Ctr., Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT M.D. Anderson Cancer Ctr., Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108338095","display_name":"Kian K Ang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kian K. Ang","raw_affiliation_strings":["1UT M.D. Anderson Cancer Ctr., Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT M.D. Anderson Cancer Ctr., Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"71","issue":"8_Supplement","first_page":"2488","last_page":"2488"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.95169997215271,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.95169997215271,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.027300000190734863,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11176","display_name":"Radiation Therapy and Dosimetry","score":0.004100000020116568,"subfield":{"id":"https://openalex.org/subfields/3108","display_name":"Radiation"},"field":{"id":"https://openalex.org/fields/31","display_name":"Physics and Astronomy"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/head-and-neck-squamous-cell-carcinoma","display_name":"head and neck squamous cell carcinoma","score":0.9549999833106995},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.9089999794960022},{"id":"https://openalex.org/keywords/igf-1-receptor","display_name":"IGF-1 receptor","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.9520000219345093},{"id":"https://openalex.org/keywords/radiosensitization","display_name":"radiosensitization","score":0.8700000047683716},{"id":"https://openalex.org/keywords/radioresistance-biology","display_name":"radioresistance (biology)","score":0.9110000133514404},{"id":"https://openalex.org/keywords/receptor-tyrosine-kinase-signaling","display_name":"receptor tyrosine kinase signaling","score":0.8069999814033508},{"id":"https://openalex.org/keywords/medication-scheduling","display_name":"drug scheduling","score":0.5619999766349792},{"id":"https://openalex.org/keywords/ionizing-radiation","display_name":"ionizing radiation","score":0.5569999814033508},{"id":"https://openalex.org/keywords/clonogenic-survival","display_name":"clonogenic survival","score":0.7129999995231628}],"concepts":[{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.9783501625061035},{"id":"https://openalex.org/C58962609","wikidata":"https://www.wikidata.org/wiki/Q2353022","display_name":"Radioresistance","level":3,"score":0.8166818022727966},{"id":"https://openalex.org/C2776833033","wikidata":"https://www.wikidata.org/wiki/Q1783924","display_name":"Head and neck squamous-cell carcinoma","level":4,"score":0.679423451423645},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6592462062835693},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.6411536335945129},{"id":"https://openalex.org/C206684579","wikidata":"https://www.wikidata.org/wiki/Q4387689","display_name":"Radiosensitivity","level":3,"score":0.5579737424850464},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5254784226417542},{"id":"https://openalex.org/C26375932","wikidata":"https://www.wikidata.org/wiki/Q118226","display_name":"Growth factor receptor","level":3,"score":0.48083481192588806},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.4233972728252411},{"id":"https://openalex.org/C2776530083","wikidata":"https://www.wikidata.org/wiki/Q1783924","display_name":"Head and neck cancer","level":3,"score":0.3903535008430481},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.34756457805633545},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32736289501190186},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3261251449584961},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29755744338035583},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.2385801374912262},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.1789911985397339}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2011-2488","doi":"https://doi.org/10.1158/1538-7445.am2011-2488","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2011-2488","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2039579824","https://openalex.org/W1994540885","https://openalex.org/W2491737197","https://openalex.org/W2528307062","https://openalex.org/W2092946571","https://openalex.org/W2314598666","https://openalex.org/W2080380360","https://openalex.org/W3080524290","https://openalex.org/W2566975754","https://openalex.org/W2067624522"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"Emerging":[2],"data":[3,413],"show":[4],"crosstalk":[5],"among":[6],"receptor":[7,15,21],"tyrosine":[8],"kinases":[9],"(RTK),":[10],"e.g.,":[11],"epidermal":[12],"growth":[13,19],"factor":[14,20],"(EGFR)":[16],"and":[17,33,45,54,70,81,88,96,105,196,218,244,263,291,374,423],"insulin-like":[18],"(IGF-1R).":[22],"Higher":[23],"IGF-1R":[24,89,258,277,366,375,389],"expression":[25],"was":[26,147,273,350,362,398,404],"associated":[27,399],"with":[28,224,400,425],"resistance":[29,402],"to":[30,60,68,72,134,151,176,209,299,317,335,370],"EGFR":[31,65,87,144,272,300,337,349,356,373],"inhibitors":[32],"ionizing":[34],"radiation":[35,235,286],"(IR).":[36],"We":[37],"investigated":[38],"the":[39,50,148,190,246,285,293,318,443,448],"effects":[40,93],"of":[41,52,86,94,114,131,165,192,216,248,296,304,442,447],"cetuximab":[42,95,210,225,254,422],"(EGFR":[43],"antibody)":[44,48],"A12":[46,97,153,424],"(IGF-1R":[47],"on":[49,100,157,203,282,313,372],"response":[51,287],"head":[53],"neck":[55],"squamous":[56],"cell":[57,101,138,158,168],"carcinoma":[58],"(HNSCC)":[59],"IR,":[61,187,212],"escape":[62],"mechanisms":[63],"from":[64,174,420],"blockade":[66],"leading":[67],"radioresistance,":[69],"strategies":[71],"overcome":[73],"it.":[74],"Methods:":[75],"Three":[76],"HNSCC":[77],"models":[78],"(HN-5,":[79],"FaDu,":[80,243,290,322,388],"UMSCC-1)":[82],"expressing":[83,145],"different":[84],"levels":[85],"were":[90,110,116,122],"studied.":[91],"The":[92,142],"(from":[98],"Imclone)":[99],"viability":[102,130,159],"(MTS":[103],"assay)":[104,109],"radiosensitivity":[106,191,247,295,316],"(clonogenic":[107],"survival":[108],"determined.":[111],"Various":[112],"scheduling":[113],"drugs":[115],"examined.":[117],"Alterations":[118],"in":[119,136,232,237,242,259,269,275,289,321,427],"target":[120],"signaling":[121,354,376,395],"analyzed":[123],"by":[124,339,365,407,431],"Western":[125,250],"blots.":[126],"Results:":[127],"Cetuximab":[128],"inhibited":[129],"cells":[132],"(14":[133],"53%)":[135],"a":[137,162,233,310,351,392],"type":[139],"dependent":[140],"manner.":[141],"highest":[143],"HN-5":[146,193,217],"most":[149],"responsive":[150],"cetuximab.":[152],"had":[154,279],"no":[155,201,280],"effect":[156,202,281,312],"but":[160,200,323],"elicited":[161],"moderate":[163],"radiosensitization":[164],"all":[166],"three":[167],"lines":[169],"(enhancement":[170],"factors,":[171],"EFs,":[172],"ranged":[173],"1.11":[175],"1.67).":[177],"Cetuximab,":[178],"given":[179],"6":[180],"h":[181,185,207,228],"before":[182,211],"till":[183],"66":[184],"after":[186,229],"significantly":[188],"enhanced":[189,245,364],"(EF,":[194,198],"2.55)":[195],"FaDu":[197,219,260],"1.46),":[199],"UMSCC-1.":[204,222,249,297],"A":[205],"48":[206],"exposure":[208],"however,":[213,271],"increased":[214,292,325,401],"radioresistance":[215,241],"without":[220],"affecting":[221],"Continuing":[223],"for":[226,451],"72":[227],"IR":[230,426],"resulted":[231],"net":[234,294],"sensitization":[236,360,382],"HN-5,":[238,283,314,348],"partially":[239,288],"reversed":[240],"blots":[251],"revealed":[252],"that":[253,332,361,403,415],"(48":[255],"h)":[256],"upregulated":[257,274],"(2.28":[261],"fold)":[262,266],"UMSCC-1":[264,326,368],"(1.26":[265],"but,":[267],"not":[268,308,363],"HN-5;":[270],"HN-5.":[276],"inhibition":[278,301,338,357,379],"reverted":[284,315,406],"Compared":[298],"alone,":[302],"co-targeting":[303,408],"both":[305],"pathways":[306],"did":[307],"yield":[309],"better":[311,381],"baseline":[319],"level":[320],"further":[324],"radiosensitivity.":[327],"Conclusion:":[328],"This":[329],"study":[330],"showed":[331],"tumors":[333],"responded":[334],"prolonged":[336],"upregulating":[340],"other":[341],"pro-survival":[342,353,394],"RTK":[343],"signaling,":[344],"e.g.":[345],"IGF-1R.":[346,409],"In":[347,387],"main":[352],"as":[355,377,396],"yielded":[358,380],"consistent":[359],"blockade.":[367,386],"seemed":[369],"rely":[371],"dual":[378],"than":[383],"single":[384],"pathway":[385],"could":[390],"become":[391],"major":[393],"it":[397],"only":[405],"Taken":[410],"together":[411],"our":[412],"suggest":[414],"therapeutic":[416],"benefit":[417],"would":[418],"result":[419],"combining":[421],"some":[428],"HNSCC.":[429],"Supported":[430],"P0-1":[432],"CA-06294":[433],"Citation":[434],"Format:":[435],"{Authors}.":[436],"{Abstract":[437],"title}":[438],"[abstract].":[439],"In:":[440],"Proceedings":[441],"102nd":[444],"Annual":[445],"Meeting":[446],"American":[449],"Association":[450],"Cancer":[452,462],"Research;":[453],"2011":[454],"Apr":[455],"2-6;":[456],"Orlando,":[457],"FL.":[458],"Philadelphia":[459],"(PA):":[460],"AACR;":[461],"Res":[463],"2011;71(8":[464],"Suppl):Abstract":[465],"nr":[466],"2488.":[467],"doi:10.1158/1538-7445.AM2011-2488":[468]},"counts_by_year":[],"updated_date":"2026-10-03T13:16:28.481748","created_date":"2016-06-24T00:00:00"}